NVCN Share Price Performance
CA$0
0.00 (0.00%)
Price CA$0
Share Pricen/a
Is Neovasc (TSE:NVCN) Using Too Much Debt?
Jan 06
Neovasc Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
NVCN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Neovasc Inc. Key Details
Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
- -14.93
- -33.37%
- -1,082.90%
- 79.8%
About NVCN
- Founded
- 2000
- Employees
- 60
- CEO
- WebsiteView website
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.
